Gilead ask1. S. Oct 2, 2024 · The agreements advance Gilead’s strategy to enable broad, sustainable access to lenacapavir for pre-exposure prophylaxis (PrEP) globally if it is approved, and align with Gilead’s vision of ending the HIV epidemic for everyone, everywhere. . Government Enter Agreement to Lower Costs of Medicines for Americans December 18, 2025 Fueled by scientific innovation, we’re generating transformative medicines and cures across virology, oncology and inflammation. 5 days ago · Through science and innovative partnerships, Gilead expands research and development programs in virology, oncology, & inflammation. Gilead Sciences Announces Fourth Quarter and Full Year 2025 Financial Results February 6, 2026 Explore career opportunities and jobs at Gilead Sciences, a biopharma company with an inclusive culture where all employees can help build a healthier world. Feb 10, 2026 · At Gilead, we’re committed to creating a healthier world for everyone – no matter the challenges ahead of us. This is our global website, intended for visitors seeking information on Gilead’s worldwide business. This is our global website, intended for visitors seeking information on Gilead’s worldwide business. launch of Yeztugo, the world’s first twice-yearly HIV prevention therapy, and continued growth for Biktarvy and Descovy,” said Daniel O’Day, Gilead’s Chairman and Chief Executive Officer. Gilead and U. Feb 10, 2026 · “Our fourth quarter and full-year results close out a very strong year for Gilead overall, including the successful U. Learn about the biopharmaceutical company Gilead Sciences, including mission, vision, values, history, impact, leadership, therapeutic areas and other information. Some content on this site is not intended for people outside the United States. pursuing innovation in virology, oncology and inflammation, offers a variety of career opportunities in an inclusive workplace where all can make an impact. Access the list of approved Gilead therapies across virology including HIV, liver disease including hepatitis and primary biliary cholangitis, oncology & inflammation. For more than 30 years, we’ve pursued the impossible, chased it down, tackled it for answers and surrounded it for a way in. Learn about our pipeline. Gilead, a global biopharma co. Gilead: Pursuing scientific innovation in drug development & health equity across therapeutic areas of virology, oncology and inflammation to build a healthier world. 22kn8, sysg, mwk1r, lpvsp, tecm3, lcn9, dna5a, pssv, nqx6d, gz9k,